Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Disease Area Cancer

Anticipating NRAS Resistance

Every medical treatment is a tradeoff between benefit and side effect – and part of any physician’s job is to determine whether or not the downsides to a given treatment are a worthwhile price to pay for its potential health benefits. One factor in the therapeutic equation is resistance: what good is a treatment if the patient’s disease can resist its effects?

Establishing whether or not a disease exhibits resistance mechanisms is especially important when it involves patients whose illnesses could be fatal if left untreated. A team at The University of Texas MD Anderson Cancer Center, led by Lawrence Kwong, decided to tackle this issue in patients with NRAS melanoma. To learn more, we spoke with Lawrence Kwong, Assistant Professor in the Department of Translational Molecular Pathology at MD Anderson.

Enjoy our FREE content!

Log in or register to read this article in full and gain access to The Translational Scientist’s entire content archive. It’s FREE and always will be!

Login if you already created an account

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Or Login as a Guest or via Social Media

About the Author

William Aryitey

My fascination with science, gaming, and writing led to my studying biology at university, while simultaneously working as an online games journalist. After university, I travelled across Europe, working on a novel and developing a game, before finding my way to Texere. As Associate Editor, I’m evolving my loves of science and writing, while continuing to pursue my passion for gaming and creative writing in a personal capacity.

Related Solutions

Disease Area

See how droplets are guiding precision medicine

| Contributed by Bio Rad

Disease Area

Improving Absorption Measurements through Light Source Selection

| Contributed by Ocean Optics


Send me the latest from The Translational Scientist.

Sign up now

Related Articles

Disease Area

More than METs the Eye

| Jonathan James

Tools & Techniques

Right for Patients?

| Ellen Sigal

Tools & Techniques

Express Insight into Bladder Cancer

| Michael Schubert

Most Popular

Register here

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts